Recent research that supports the safety and effectiveness of five FDA-approved weight-loss medicines shows that diet pills are an effective tool in the fight against obesity. Phenq reviews before and after were very effective.
This study examined data on five prescribed weight-loss drugs to see which was the safest and most efficient. It was published in the Journal of the American Medical Association. All the drugs were FDA-approved for the treatment of obesity, including orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide.
28 clinical trials that involved overweight or obese adults and compared any of the weight-loss medications to inactive placebos were included in the analysis. More than 29,000 patients total who were all monitored for at least a year during the intervention were included in the analysis.
The good news is that after a year, all tests were more successful at promoting weight loss than a placebo. Compared to 44–75 percent of individuals on weight loss medications, only 23% of those taking the placebo experienced at least a 5% drop in body weight after a year. On average, participants who took weight-loss drugs dropped 3–19 pounds more than those who took a placebo.
But certain weight-loss medications worked better than others. Overall, liraglutide and phentermine-topiramate were the most successful in assisting patients to lose 5% of their body weight. In comparison to the placebo, patients on phentermine-topiramate were nine times more likely to drop five percent of their body weight than were those taking liraglutide, who were roughly six times more likely.
The scientists do point out, nevertheless, that patients on liraglutide and naltrexone-bupropion were more likely than others to cease taking their medications as a result of side effects or adverse outcomes.
Nevertheless, research supports the safety and efficacy of prescription weight-loss medications for people who are overweight or obese. For patients who are having trouble losing weight, medication may be a helpful therapy choice when combined with behavioral therapies and lifestyle changes. And out of the five medications that have been approved by the FDA, liraglutide, and phentermine-topiramate may be the best choice.
To evaluate the long-term effects of weight reduction medicine, the authors point out that more research is necessary. Even though the most recent analysis covered more than 29,000 patients, only the data from the first year were included. Researchers are working to better understand the long-term efficacy and safety of medications used to treat obesity.
